Fig. 7
Clinical significance of the risk signature. A Association between clinicopathological parameters and risk scores in the TCGA-LIHC cohort (upper), percentage of tumor stage, pathological grade, and T stage between different risk groups (below). B Boxplots of distribution of risk scores in patients with distinct clusters, tumor stage, pathological grade, as well as T stage in the TCGA-LIHC cohort. C Sankey diagram displayed the potential liner link among the cluster, risk status, and patients’ survival state. D Correlation matrix among risk genes in the prognostic model. E The risk score calculated by the regression coefficient of each model gene was demonstrated to be an independent hazard factor for patients’ prognosis both in the TCGA-LIHC, GSE14520, and ICGC-LIRI cohorts. (*p < 0.05; ***p < 0.001)